CIK 0001404644
- Non-accelerated filer
- Smaller reporting company
Neurogene Inc.
Sign in to watch- Ticker
- NGNE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 980542593
- Phone
- +1 877-237-5020
- Business address
- 535 W 24TH STREET, 5TH FLOOR, NEW YORK, NY, 10011
- Former names
- Neoleukin Therapeutics, Inc., AQUINOX PHARMACEUTICALS, INC, AQUINOX PHARMACEUTICALS (USA) INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 38 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-05-05 | Nolan Sean P. Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2019-10-10 | Nolan Sean P. Director | Grant or award · Stock Option (right to buy) | +22,000 | 22,000 | ||
| 2018-05-07 | Nolan Sean P. Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2017-05-08 | Nolan Sean P. Director | Grant or award · Stock Option (Right to Buy) | +9,000 | 9,000 | ||
| 2016-05-09 | Nolan Sean P. Director | Grant or award · Stock Option (Right to Buy) | +7,500 | 7,500 |
Page 1 of 1 · 5 trades